| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 73 |
| 1 | METHOTREXATE | 68 |
| 2 | TACROLIMUS | 67 |
| 3 | MYCOPHENOLATE MOFETIL | 66 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 66 |
| 5 | FLUDARABINE PHOSPHATE | 61 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 61 |
| 7 | TACROLIMUS OINTMENT 0.1% | 61 |
| 8 | CYCLOSPORINE | 57 |
| 9 | PREDNISONE | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELUMOSUDIL | 12 | 0.0036 |
| 1 | CETYLPYRIDINIUM CHLORIDE | 2 | 0.0031 |
| 2 | THIOTEPA | 28 | 0.0029 |
| 3 | BUSULFAN | 39 | 0.0024 |
| 4 | FLUDARABINE PHOSPHATE | 61 | 0.0015 |
| 5 | ALEMTUZUMAB | 25 | 0.0013 |
| 6 | PENICILLIN V POTASSIUM | 3 | 0.0012 |
| 7 | ASCIMINIB | 4 | 0.0011 |
| 8 | GLOFITAMAB | 3 | 0.0011 |
| 9 | MELPHALAN HYDROCHLORIDE | 28 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 76 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 68 |
| 2 | Alkylating Drug [EPC] | 66 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 57 |
| 4 | Kinase Inhibitor [EPC] | 30 |
| 5 | Janus Kinase Inhibitor [EPC] | 27 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 25 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 23 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 9 | Azole Antifungal [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 25 | 0.0013 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 3 | 0.0007 |
| 3 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 57 | 0.0004 |
| 6 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 8 | 0.0004 |
| 8 | Cannabinoid [EPC] | 3 | 0.0004 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |